Greenfield Savings Bank decreased its holdings in MetLife, Inc. (NYSE:MET – Free Report) by 31.6% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 14,287 shares of the financial services provider’s stock after selling 6,601 shares during the period. Greenfield Savings Bank’s holdings in MetLife were worth $1,177,000 as of its most recent SEC filing.
Other institutional investors have also made changes to their positions in the company. Quaker Wealth Management LLC boosted its stake in shares of MetLife by 198.2% during the 2nd quarter. Quaker Wealth Management LLC now owns 333 shares of the financial services provider’s stock valued at $27,000 after buying an additional 672 shares during the period. Evolution Wealth Management Inc. bought a new position in MetLife during the second quarter valued at approximately $35,000. MTM Investment Management LLC bought a new position in MetLife during the second quarter valued at approximately $37,000. GFG Capital LLC acquired a new stake in MetLife in the second quarter valued at approximately $38,000. Finally, Abound Wealth Management grew its position in MetLife by 652.3% in the second quarter. Abound Wealth Management now owns 489 shares of the financial services provider’s stock worth $39,000 after acquiring an additional 424 shares in the last quarter. 94.99% of the stock is currently owned by institutional investors and hedge funds.
MetLife Stock Performance
MET opened at $82.68 on Tuesday. The company has a quick ratio of 0.18, a current ratio of 0.18 and a debt-to-equity ratio of 0.54. The stock’s 50 day moving average price is $78.47 and its two-hundred day moving average price is $78.79. The firm has a market capitalization of $54.47 billion, a P/E ratio of 15.57, a price-to-earnings-growth ratio of 0.79 and a beta of 0.76. MetLife, Inc. has a 12-month low of $65.21 and a 12-month high of $88.09.
MetLife Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Tuesday, December 9th. Investors of record on Tuesday, November 4th were paid a $0.5675 dividend. This represents a $2.27 annualized dividend and a dividend yield of 2.7%. The ex-dividend date was Tuesday, November 4th. MetLife’s dividend payout ratio (DPR) is presently 42.75%.
Analyst Upgrades and Downgrades
A number of research analysts have recently weighed in on the stock. Keefe, Bruyette & Woods cut their price target on shares of MetLife from $92.00 to $90.00 and set an “outperform” rating on the stock in a report on Tuesday, November 11th. Weiss Ratings restated a “hold (c+)” rating on shares of MetLife in a report on Monday, December 8th. UBS Group decreased their price target on MetLife from $96.00 to $95.00 and set a “buy” rating for the company in a research note on Thursday, November 6th. Wolfe Research raised MetLife to a “strong-buy” rating in a research report on Tuesday, September 16th. Finally, Mizuho set a $101.00 price objective on shares of MetLife in a research note on Monday. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $95.55.
Read Our Latest Research Report on MetLife
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
See Also
- Five stocks we like better than MetLife
- Where to Find Earnings Call Transcripts
- Pfizer Adds to Its Big Bet on Weight Loss Drugs
- Consumer Staples Stocks, Explained
- ServiceNow’s $7 Billion Gamble: Panic or Opportunity?
- Options Trading – Understanding Strike Price
- Dell and HP Are Raising Prices—And Investors Should Take Note
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.
